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Objective: To determine the value of the procalcitonin test used for early diagnosis of
sepsis and to study the course and treatment of burn sepsis in patients with severe burns.
Methods: Eighty patients in the Burn Department of Republican Scientiﬁc Centre of
Emergency Medical Care, aged 17–75 years with burn injuries covering 30%–85% of the
body surface, were enrolled in the study. Procalcitonin is marker of sepsis, procalcitonin
> 2 ng/mL, sensitivity −89%, speciﬁc feature −94%.
Results: The result showed that among septic patients with severe burns, rational use of
intensive therapy for burn sepsis and septic shock in combination with parentrial ozo-
notherapy resulted in decreases of syndrome of poly organ insufﬁciency and lethal out-
comes from 70% accordingly. The result allows the conclusion that the treatment
examined leads to a signiﬁcant increase in survival coefﬁcient.
Conclusions: This in turn conﬁrms the efﬁcacy of early necrectomy and auto dermo-
plasty of deep burn wounds in victims with sepsis.1. Introduction
Burn trauma remains one of the real problems of modern
medicine, because of its heavy clinical course, the difﬁculties of
treating the victims, the high mortality rate, and sometimes un-
acceptable results of treatment. However, according to the
World Health Organization data, more than 95% of fatal ﬁre-
related burns in 2002, for example, occurred in low- and
middle-income countries [1].
In spite of great success achieved in burn treatment, a lethal
outcome among severely burnt patients remains high even in
specialized hospitals. Lethality is particularly high in critical
(40%–50% of body surface) and extra critical (over 50%) deep
burns [2,3].
Burn sepsis is a systemic response to infection, characterized
by inﬂammatory reaction symptoms on the background of a
marked inﬂammatory process [4–6]. The data on contemporary
statistics, devoted to patients with generalized inﬂammatory
complications show their signiﬁcant number and also identify
the tendency for constant growth to 78%–80% [7–9].
In burn sepsis pathogenesis, an important role is played by
anti-inﬂammatory cytokines: interleukine-1, tumor factor,inteleleukine-6, interleukine-8 and others, which form speciﬁc
body responses to so-called cytokine storms. Damage to
different organs and tissues as a result of interleukine effects
results in marked inﬂammatory disturbances, accompanied by
development of interstitial edema (shock lung, shock kidney,
etc.) formation of great number of circulating immune com-
plexes, and others [10].
Severe burn trauma causes the systematic inﬂammatory
response syndrome, which leads to damage from possible sepsis
and severe sepsis development [11].
In light of the severity of these issues, the study aimed to
determine the value of the procalcitonin test used for early
diagnosis of sepsis and to study the course and treatment of burn
sepsis in patients with severe burns.
2. Materials and methods
Over a period of 2010–2012, 80 patients with sepsis were
treated at Burns Department of the Republican Scientiﬁc Centre
of Emergency Medical Care, Samarkand, Uzbekistan. General-
ization of purulent infection is most frequently marked in deep
burns of more than 40% of the body surface [(45.1% ± 1.5%) on
average]. The patients underwent procalcitonin test for early
diagnosis.
Eighty patients aged 17–75 years with burn injuries covering
30%–85% of the body surface were enrolled in the study. All
patients were admitted to the hospital during the ﬁrst 12 h after
Table 1
Type of strains isolated from the blood of patients with burns.
Type of strains Number of samples Including resistant
n % n %
S. aureus 13 37.2 11 31.4
Enterococcus spp. 10 28.6 10 28.7
P. aeruginosa 5 14.3 2 5.8
Staphylococcus
epidermidis
3 8.6 1 2.8
Candida spp. 2 5.7 0 0.0
E. coli 1 2.8 1 2.8
Acinetobacter spp. 1 2.8 1 2.8
Total 35 100.0 26 74.3
E. coli: Escherichia coli.
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accompanying chronic diseases in all examined patients. For the
purposes of the investigation, patients with sepsis were sub-
divided into 2 groups.
In addition to standard clinical laboratory test, the following
were carried out: measurement of body temperature and heart
rate, clinical and biochemical analyses of blood and urine, and
microbiological analysis of discharge from burn wounds with
determination of ﬂora sensitivity to antibiotics according to the
procalcitonin (PCT)-Q (BRAHMS, Germanya) method of
measuring PCT level in blood serum on 2, 3, 5, 7, and 10 days
after the burn trauma.
PCT-Q is an immunochromatographic test for half-amount
determination of PCT level, used for diagnosis and control of
therapy for acute bacterial infections and sepsis. PCT-Q requires
only a 30 min incubation period and not need calibration and
additional apparatus. The advantages of this method include:
simplicity of usage; absence of complex equipment; and short
time for receiving results. To obtain PCT sensitivity ﬁndings,
speciﬁc features, positive prognostic signiﬁcance (PPS), and
negative prognostic signiﬁcance (NPS) were determined.
On the background of sepsis PCT concentration was
(4.8 ± 1.1) ng/mL in the 50 patients in Group 1, sensitivity 67%,
speciﬁc features 92%, PPS 85%, NPS 81%. For the 30 patients
in Group 2, with severe course of sepsis, PCT level was
(15.6% ± 2.2) ng/mL, sensitivity 3.3%, speciﬁc futures 98%,
PPS 83%, NPS 81%.
Analysis of microﬂora and its sensitivity to antibacterial
preparations was carried out for 45 patients, aged 16–75 years, of
whom 29 were males and 16 females, with deep burns covering
25%–65% of the body surface [(39.5% ± 5.0%) on the average].
Examination was carried out on admission, then on 4–5 and
10–15 day of treatment. For sterility, blood was taken from
central vein. Cultivation of microorganisms was carried out
according to standard methods of microbiological blood study
on a double medium.
The result was estimated according to the presence of col-
onies of microorganisms. In addition, analysis of sowings from
the wounds to microﬂora was carried out. Sensitivity to 15–20
antibiotics produced in foreign countries was determined in
isolated pathogenetic and conventionally pathogenetic
microorganisms.
3. Results
Group 1 consisted of 50 patients with Index Frank > 70 units,
in the acute period of burn trauma (3–6 days); signiﬁcant bac-
terial contamination (> 10.5 KOE/g) was revealed, PCT level
was < 2 ng/mL and scale assessment was SOFA 11–12.
Group 2 consisted of 30 patients with severe burns with In-
dex Frank > 100 units, PCT level of more than 2 ng/mL in all
cases correlated with development of a burn sepsis clinical
picture. In 5 patients with PCT levels of more than 10 ng/mL,
speciﬁc features were 95%, and NPS 70%; diagnosis of burn
sepsis was conﬁrmed morphologically as well. Reliable effect on
patients death was presented by PCT index > 2 ng/mL and scale
assessment SOFA 18–20.
Thus, PCT test is prospective in diagnosis of burn sepsis.
PCT levels in blood of more than 2 ng/mL in patients with burn
trauma with Index Frank > 70 units in the acute period of burn
injury is evidence for the expediency of performing a dees-
calation regimen of antibacterial chemotherapy.In 50 (62.5%) patients with burns (Group 1) with signs of
burn sepsis, standard intensive therapy with intravenous infusion
of 200 mL ozonized physiological solution was performed
during the term of (11.54 ± 2.11) days after receiving burns,
with ozone concentration of 4 mg/L the ﬂuid, once every 24 h
for 10 days at the stage of burn shock and acute burn toxemia.
The 30 patients with burns in Group 2 showed Frank Index of
105.75 ± 3.54 conventional units and signs of burn sepsis.
Complex intensive therapy was carried out during 10–11 days
after receiving burn trauma (at stage of burn shock and acute
burn toxemia).
In blood sowings with positive results, 13 cases (37.2%)
showed resistance to Staphylococcus aureus (S. aureus), 10
cases (28.6%) to Enterococcus, 5 cases (14.3%) to Pseudo-
monas aeruginosa (P. aeruginosa), with these 74.3% were
polyresistant strains (Table 1).
Of the studied samples, 42 cases showed positive results to
S. aureus (37.8%), 30 cases to bacteria of intestinal bacilli
(27.1%), 20 cases to P. aeruginosa (18.0%). Polyresistance of
microorganisms from wounds to antibacterial preparations was
noted in 63.1% in purulent strains of burn wound (Table 2).
The most frequent strains of sepsis are S. aureus and
P. aeruginosa, which are discharged from burn wounds and,
according to our ﬁndings, predominate at 65%–85% in septic
patients. Correlation of sowing of S. aureus and P. aeruginosa
strains in patient blood with burn sepsis is 2:1. Less often, the
agents of sepsis are Escherichia coli, Acinetobacter spp.,
Enterobacter spp., B-hemolytic streptococcus, and non-
sporogenetic anaerobic bacteria. The most severe septic course
is noted in discharge of three or more microorganisms in
hemoculture.
Taking into account clinic laboratory ﬁndings (Hb, A/G co-
efﬁcient, lymphocytes, leucocytes, body temperature higher than
38 C) and 3 times Regis rated bacterimia, we diagnosed sepsis
in 80 patients with burns, which accounts for 4.1% of the total
number of victims and 38% among patients with severe burns.
In septic patients with rate of heart beats more than 90 b/m,
respiratory rate more than 20 per minute, average Hb level 72 g/
L, lymph of 11%, A/G coefﬁcient of 0.97, there was marked
leucocytosis of more than 12 × 10/mL or leukopenia of less than
4 × 10/mL or the immature form of more than 10% and body
temperature higher than 38 C or lower than 35 C.
In patient with critical burns, the risk of developing gener-
alized infections complications increases. When such patients
have deep burns covering more than 20% of the body surface,
they undergo complex therapy consisting of antibacterial pre-
ventive therapy and then treatment of complications
Table 2
Purulent strains of burn wound.




n % n %
Staphylococcus aureus 42 37.8 37 33.3
E. coli 30 27.1 10 9.1
Pseudomonas aeruginosa 20 18.0 11 9.9
Staphylococcus epidermidis 10 9.0 3 2.7
Streptococcus spp. 4 3.6 4 3.6
Enterococcus spp. 3 2.7 3 2.7
Acinetobacter spp. 2 1.8 2 1.8
Total 111 100.0 70 63.1
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rations are introduced intravenously. Development of infections
complications is considered to be absolute indication for
providing immediate and intensive antibacterial therapy.
Administration of antibacterial preparations must be based on a
complex evaluation of the patients' condition, taking into
consideration the extent of the injury, the stage of burn disease,
complications, degree of invasion of the burn injury by micro-
ﬂora, immune status, patients' age and the character and severity
of accompanying pathology.
Preparations of choice in septic patients with burns are pol-
ysynthetic penicillin (ampicilline, carbenicilline) along or in
combination with beta-lactamaze inhibitors (amoxicilline +
clavulone acid, ampicciline + sulbactam), aminoglycosides
(gentamycine, tobramycine and sistomycin), ftorchinolons
(oﬂoxacin, petroxacin and lomeﬂoxacin). Sandal burns with
affected bone structures are treated with lincomycin, and non-
clostridial anaerobic infections are treated with clindomycin and
metronidazol.
Of 80 patients with burn sepsis, 40 underwent operative
treatment.
In the ﬁrst group (25 patients) that underwent burn trauma,
necrectomy was performed on 5%–10% of the body surface and
the area covered with xeroderma (15 patients) or amniotic
membrane (10 patients) on an area of 500–950 cm2. Five or six
days later, necrectomy of the rest area was performed with one-
moment autodermoplasty by split skin graft (1:2). In the post-
operative period on 3–4 days in 19 patients bacterimia was ab-
sent in hemocultures. In all patients PCT level was decreasing
and did not exceed 0.5 ng/mL after early necrectomy (to
850 cm2) with one-moment autoplasty; septic signs were absent.
In the second group (17 patients) bloodless spare necrectomy
was performed, after cleaning of wounds, autoplasty on granu-
lating wounds (950–1050 cm2) was performed. Before and after
the operation hemocultures with growth sight were revealed.
During the period of 7–10 days after the operation, PCT was
limited to 2–5 ng/mL, which conﬁrms continuation of the burn
sepsis course.
Among patients of Group 1, lethal outcomes were 20% (5
patients); in Group 2, it was 41.2% (7 patients).
4. Discussion
Burn sepsis is a systemic host response to infection and can
in some conditions lead to severe sepsis. According to the au-
thors' data 23%–82% of patients die of sepsis in late periods of
septic disease [12–14].Severe burn trauma causes the syndrome of systematic in-
ﬂammatory response with possible sepsis and severe sepsis
development [15,16].
PCT was discovered accidentally and described for the
ﬁrst time in 1993 as a new marker of bacterial infection. It is
prohormone of calcitonine and is related to anti-inﬂamatory
cytokines. Procalcitonin is a polypeptide with a molecular
mass of 12.793 Da. It develops in the neuroendoctine cells
(gland, lungs, liver). In bacteriemia the unsplitted PCT
molecule is discharged from cells, and the calcitonin level
does not increase. The concentration of PCT circulating in
the plasma of healthy people is very low at 0.01 ng/mL
however, in severe bacterial infections it can increase to 20–
200 ng/mL.
We designed prospective study to validate the diagnosis of
burn sepsis. The results showed that therapy for burn sepsis and
septic shock in combination with parenteral ozonotherapy
revealed that among septic patients with severe burns, syndrome
of poly organ insufﬁciency and lethal outcome decreased from
70% to 80%.
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